Longitudinal Analysis of Matched Patient Biospecimens Reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with a complex tumor microenvironment. To gain an understanding of the chemotherapy-induced changes in the microenvironment, we examined matched pre- and post-treatment patient tissue specimens and found near-universal enrichment of axonal guidance genes in cancer-associated fibroblasts after treatment. Here, we deposit the raw single cell RNA sequenced data of the longitudinally collected samples of 5 patients. Additionally, pertaining to the in vitro work in our study, we include the raw bulk RNA sequencing data of 3 patient-derived fibroblast lines (untreated and treated with Gemcitabine in vitro for 120 hours, performed in technical triplicate), as well as the raw bulk RNA sequencing of 2 patient-derived PDAC organoid lines, performed in technical triplicate.
- Type: Genotype/Expression
- Archive: The database of Genotypes and Phenotypes (dbGaP)
